DOGWOOD THERAPEUTICS INC (DWTX) Stock Earnings & Estimates
USA - NASDAQ:DWTX - US92829J2033 - Common Stock
5.7962 USD
+0.18 (+3.14%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | N/A | N/A 82.41% | N/A 73.21% | N/A 117.15% | ||||||||
| EBITDA YoY % growth | N/A | N/A | N/A | N/A | N/A | N/A | -12.215M | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -1.96M | -2.18M -11.22% | -10.01M -359.17% | -15.64M -56.24% | -12.32M 21.23% | -5.447M 55.79% | -12.227M -124.48% | N/A -42.89% | N/A -29.32% | N/A -29.27% | N/A 51.16% | N/A 56.92% | N/A 280.25% | N/A 555.22% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | N/A | -32.75 37.35% | -7.00 78.63% | -10.92 -56.00% | N/A 15.97% | N/A 50.72% | N/A 7.44% | N/A | N/A | N/A | N/A |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | |
|---|---|---|---|
| EPS Q2Q % growth | -1.25 39.05% | -1.20 79.61% | -0.63 84.91% |
| Revenue Q2Q % growth | |||
| EBITDA Q2Q % growth | N/A | N/A | N/A |
| EBIT Q2Q % growth | -4.282M -86.08% | -4.451M 40.99% | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -1.99 -59.20% | -1.94 | -0.05 | -2.68% |
| Q1 2025 Q2Q % growth | -4.19 -139.43% | -2.42 | -1.77 | -72.96% |
| Q4 2024 Q2Q % growth | -5.87 -291.33% | -1.44 | -4.43 | -306.71% |
| Q3 2024 Q2Q % growth | -2.05 -36.67% | -1.20 | -0.85 | -70.80% |
| Q2 2024 Q2Q % growth | -1.25 37.50% | -1.61 | 0.36 | 22.60% |
| Q1 2024 Q2Q % growth | -1.75 12.50% | -1.02 | -0.73 | -71.57% |
| Q4 2023 Q2Q % growth | -1.50 45.45% | -2.30 | 0.79 | 34.64% |
| Q3 2023 Q2Q % growth | -1.50 78.57% | -2.42 | 0.92 | 38.08% |
| Q2 2023 Q2Q % growth | -2.00 81.82% | -1.79 | -0.21 | -12.04% |
| Q1 2023 Q2Q % growth | -2.00 83.33% | -5.10 | 3.10 | 60.78% |
| Q4 2022 Q2Q % growth | -2.75 79.63% | -3.95 | 1.20 | 30.42% |
| Q3 2022 Q2Q % growth | -7.00 42.86% | -12.50 | 5.50 | 43.98% |
| Q2 2022 Q2Q % growth | -11.00 13.73% | -12.88 | 1.88 | 14.58% |
| Q1 2022 Q2Q % growth | -12.00 | -13.64 | 1.64 | 12.04% |
| Q4 2021 Q2Q % growth | -13.50 | -17.21 | 3.71 | 21.57% |
| Q3 2021 Q2Q % growth | -12.25 | -17.72 | 5.47 | 30.88% |
| Q2 2021 Q2Q % growth | -12.75 | -14.28 | 1.53 | 10.71% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0.81% | 38.44% | 9% | 6.12% |
| Revenue | N/A | N/A | N/A | N/A |